ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

Funding Opportunities

April 26, 2002

Avoiding the Hippocampus During Whole-Brain Radiotherapy Can Preserve Memory Function

September 27, 2013

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009